Loading...
Opyl Limited
OPL.AX•ASX
Healthcare
Medical - Healthcare Information Services
A$0.02
A$0.00(0.00%)
Opyl Limited (OPL.AX) Financial Performance & Income Statement Overview
Review Opyl Limited’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
-35.65%
↓ 35.65%
Operating Income Growth
-38.40%
↓ 38.40%
Net Income Growth
-81.33%
↓ 81.33%
Operating Cash Flow Growth
-50.75%
↓ 50.75%
Operating Margin
-1408.30%
↓ 1408.30%
Gross Margin
-624.76%
↓ 624.76%
Net Profit Margin
-1293.90%
↓ 1293.90%
ROE
1264.99%
↑ 1264.99%
ROIC
888.54%
↑ 888.54%
Opyl Limited (OPL.AX) Income Statement & Financial Overview
Review Opyl Limited's (OPL.AX) income statement with detailed quarterly and annual figures.
| Metric | Q2 2025 | Q4 2024 | Q2 2024 | Q4 2023 |
|---|---|---|---|---|
| Revenue | $42146.00 | $153949.00 | $243688.00 | $364896.00 |
| Cost of Revenue | $330453.00 | $1.09M | $1.17M | $846201.00 |
| Gross Profit | -$288000.00 | -$937000.00 | -$409000.00 | -$481305.00 |
| Gross Profit Ratio | -$6.83 | -$6.09 | -$1.68 | -$1.32 |
| R&D Expenses | $180045.00 | $153316.00 | $122366.00 | $174247.00 |
| SG&A Expenses | $461021.00 | $742100.00 | $344350.00 | $449551.00 |
| Operating Expenses | $641066.00 | $895416.00 | $466716.00 | $623798.00 |
| Total Costs & Expenses | $971519.00 | $1.99M | $1.64M | $1.47M |
| Interest Income | $427.00 | $3400.00 | $458.00 | $259.00 |
| Interest Expense | $41415.00 | $13199.00 | $413261.00 | $0.00 |
| Depreciation & Amortization | $5700.00 | $14118.00 | $11131.00 | $13000.00 |
| EBITDA | -$637000.00 | -$1.83M | -$1.38M | -$1.09M |
| EBITDA Ratio | -$15.11 | -$11.87 | -$5.67 | -$2.99 |
| Operating Income | -$929000.00 | -$1.83M | -$1.39M | -$1.11M |
| Operating Income Ratio | -$22.04 | -$11.90 | -$5.72 | -$3.03 |
| Other Income/Expenses (Net) | $246181.00 | -$21843.00 | -$413000.00 | -$845.00 |
| Income Before Tax | -$683000.00 | -$1.85M | -$1.81M | -$1.11M |
| Income Before Tax Ratio | -$16.21 | -$12.04 | -$7.42 | -$3.03 |
| Income Tax Expense | $0.00 | $0.00 | -$531000.00 | $0.00 |
| Net Income | -$683000.00 | -$1.85M | -$1.28M | -$1.11M |
| Net Income Ratio | -$16.21 | -$12.04 | -$5.24 | -$3.03 |
| EPS | -$0.004 | -$0.01 | -$0.01 | -$0.01 |
| Diluted EPS | -$0.004 | -$0.01 | -$0.01 | -$0.01 |
| Weighted Avg Shares Outstanding | $170.80M | $170.72M | $119.45M | $83.47M |
| Weighted Avg Shares Outstanding (Diluted) | $170.80M | $170.72M | $119.45M | $83.47M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan